Advertisement

In a story and headline March 17 about SurModics Inc., The Associated Press reported erroneously that the company licensed technology from ForSight Labs LLC. It is licensing technology to ForSight. The article also reported erroneously that the I-Vation drug delivery technology that is not included in the licensing deal belongs to ForSight; it belongs to SurModics.

Advertisement
Advertisement